|
Volumn 306, Issue 8, 2011, Pages 811-813
|
As production goes global, drug supply faces greater risks to safety, quality
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
HEPARIN;
INSULIN;
DRUG;
CONSUMER;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
ECONOMIC ASPECT;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
MASS MEDIUM;
PRIORITY JOURNAL;
QUALITY CONTROL;
RISK MANAGEMENT;
SAFETY;
SHORT SURVEY;
CHINA;
COMMERCIAL PHENOMENA;
COST CONTROL;
CRIME;
DRUG CONTAMINATION;
INDIA;
NOTE;
STANDARD;
UNITED STATES;
CHINA;
COMMERCE;
COST CONTROL;
CRIME;
DRUG CONTAMINATION;
DRUG INDUSTRY;
INDIA;
PHARMACEUTICAL PREPARATIONS;
QUALITY CONTROL;
SAFETY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 80052049469
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.1194 Document Type: Short Survey |
Times cited : (4)
|
References (0)
|